Nutrien Ltd.
97.63CAD
+0.9300 (+0.96%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on NTR.TO.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.79▼ | $1.21 | 0 | 3 |
| Next quarter | $1▼ | $1.07 | 2 | 1 |
| Current year | $4.96▼ | $5.65 | 3 | 2 |
| Next year | $5.08▼ | $5.2 | 4 | 1 |
Beat in 1 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $2.71 | $2.61 | -0.10 (-3.5%) |
| 2026-03-31 | $0.54 | $0.51 | -0.03 (-6.4%) |
| 2025-12-31 | $0.91 | $0.83 | -0.08 (-8.8%) |
| 2025-09-30 | $0.96 | $0.97 | +0.01 (+1.4%) |
265 ratings from 33 firms
Ratings are attributed to the research firm, not to individual analysts. Targets on listings outside the US are shown without a currency: the source does not say which one each firm used, and on cross-listed names some firms quote the US line in US dollars. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Oppenheimer | Maintained | Outperform | 80 78 | Oct 22, 2026 |
| RBC Capital | Reiterated | Outperform | 85 | Sep 18, 2026 |
| Keybanc | Initiated | Sector Weight | — | Sep 11, 2026 |
| Barclays | Maintained | Overweight | 81 78 | Aug 11, 2026 |
| Barclays | Maintained | Overweight | 85 81 | Jul 27, 2026 |
| Oppenheimer | Maintained | Outperform | 82 80 | Jul 23, 2026 |
| Jefferies | Downgraded from Buy | Hold | 96 63 | Jul 16, 2026 |
| Mizuho | Maintained | Neutral | 77 75 | Jul 14, 2026 |
| Morgan Stanley | Maintained | Overweight | 93 81 | Jul 7, 2026 |
| Scotiabank | Upgraded from Sector Perform | Sector Outperform | 80 | Jun 30, 2026 |
| Oppenheimer | Maintained | Outperform | 80 82 | May 12, 2026 |
| UBS | Maintained | Sell | 67 65 | May 11, 2026 |
| JP Morgan | Maintained | Overweight | 78 80 | May 11, 2026 |
| Scotiabank | Maintained | Sector Perform | 75 80 | May 11, 2026 |
| CIBC | Maintained | Outperformer | 90 88 | Apr 30, 2026 |
| Barclays | Upgraded from Equal-Weight | Overweight | 80 85 | Apr 27, 2026 |
| Oppenheimer | Maintained | Outperform | 78 80 | Apr 22, 2026 |
| Scotiabank | Maintained | Sector Perform | 70 75 | Apr 20, 2026 |
| Morgan Stanley | Maintained | Overweight | 77 93 | Apr 8, 2026 |
| UBS | Downgraded from Neutral | Sell | 63 67 | Mar 26, 2026 |
| B of A Securities | Maintained | Neutral | 75 81 | Mar 18, 2026 |
| BMO Capital | Maintained | Outperform | 85 90 | Mar 18, 2026 |
| CIBC | Maintained | Outperformer | 81 90 | Mar 17, 2026 |
| Wells Fargo | Upgraded from Equal-Weight | Overweight | 77 100 | Mar 13, 2026 |
| Jefferies | Upgraded from Hold | Buy | 74 96 | Mar 12, 2026 |
317 filings from 3 insiders · 0 buy / 0 sell over 6m
Officers and directors of NTR.TO, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Nutrien, Ltd.Issuer | Other | 25.4k | $71.05 | $1.80M | Sep 30, 2026 |
| Nutrien, Ltd.Issuer | Other | 25.4k | $71.02 | $1.81M | Sep 30, 2026 |
| Nutrien, Ltd.Issuer | Other | 50.8k | — | — | Sep 30, 2026 |
| Nutrien, Ltd.Issuer | Other | 25.1k | $71.79 | $1.80M | Sep 29, 2026 |
| Nutrien, Ltd.Issuer | Other | 25.1k | $71.79 | $1.80M | Sep 29, 2026 |
| Nutrien, Ltd.Issuer | Other | 50.2k | — | — | Sep 29, 2026 |
| Nutrien, Ltd.Issuer | Other | 25.0k | $72.06 | $1.80M | Sep 28, 2026 |
| Nutrien, Ltd.Issuer | Other | 25.0k | $72.03 | $1.80M | Sep 28, 2026 |
| Nutrien, Ltd.Issuer | Other | 50.1k | — | — | Sep 28, 2026 |
| Nutrien, Ltd.Issuer | Other | 25.2k | $71.52 | $1.80M | Sep 25, 2026 |
| Nutrien, Ltd.Issuer | Other | 25.2k | $71.54 | $1.80M | Sep 25, 2026 |
| Nutrien, Ltd.Issuer | Other | 50.4k | — | — | Sep 25, 2026 |
| Nutrien, Ltd.Issuer | Other | 24.1k | $74.75 | $1.80M | Sep 24, 2026 |
| Nutrien, Ltd.Issuer | Other | 24.1k | $74.83 | $1.80M | Sep 24, 2026 |
| Nutrien, Ltd.Issuer | Other | 48.2k | — | — | Sep 24, 2026 |
| Nutrien, Ltd.Issuer | Other | 23.9k | $75.39 | $1.80M | Sep 23, 2026 |
| Nutrien, Ltd.Issuer | Other | 23.9k | $75.35 | $1.80M | Sep 23, 2026 |
| Nutrien, Ltd.Issuer | Other | 47.8k | — | — | Sep 23, 2026 |
| Nutrien, Ltd.Issuer | Other | 24.0k | $75.13 | $1.80M | Sep 22, 2026 |
| Nutrien, Ltd.Issuer | Other | 24.0k | $75.12 | $1.80M | Sep 22, 2026 |
No analyst notes on NTR.TO yet.
Analyst Ratings
6 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 7 | 7 | 8 | 2 | 0 | Buy2.21 |
| 1 mo ago | 7 | 7 | 8 | 2 | 0 | Buy2.21 |
| 2 mo ago | 7 | 7 | 7 | 2 | 0 | Buy2.17 |
| 3 mo ago | 9 | 7 | 5 | 2 | 0 | Buy2.00 |
Members whose judged calls on NTR.TO have played out most reliably.
No settled calls on NTR.TO yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice